Your browser doesn't support javascript.
loading
Addition of Navitoclax to Ongoing Ruxolitinib Therapy for Patients With Myelofibrosis With Progression or Suboptimal Response: Phase II Safety and Efficacy.
Harrison, Claire N; Garcia, Jacqueline S; Somervaille, Tim C P; Foran, James M; Verstovsek, Srdan; Jamieson, Catriona; Mesa, Ruben; Ritchie, Ellen K; Tantravahi, Srinivas K; Vachhani, Pankit; O'Connell, Casey L; Komrokji, Rami S; Harb, Jason; Hutti, Jessica E; Holes, Leanne; Masud, Abdullah A; Nuthalapati, Silpa; Potluri, Jalaja; Pemmaraju, Naveen.
Afiliación
  • Harrison CN; Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.
  • Garcia JS; Dana-Farber Cancer Institute, Boston, MA.
  • Somervaille TCP; The Christie NHS Foundation Trust, Manchester, United Kingdom.
  • Foran JM; Cancer Research UK Manchester Institute, The University of Manchester, Manchester, United Kingdom.
  • Verstovsek S; Mayo Clinic, Jacksonville, FL.
  • Jamieson C; The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Mesa R; University of California San Diego Moores Cancer Center, La Jolla, CA.
  • Ritchie EK; University of Texas Health San Antonio, San Antonio, TX.
  • Tantravahi SK; Division of Hematology and Oncology, Weill Cornell Medical College, New York, NY.
  • Vachhani P; University of Utah and Huntsman Cancer Institute, Salt Lake City, UT.
  • O'Connell CL; O'Neal Comprehensive Cancer Center at UAB, Birmingham, AL.
  • Komrokji RS; University of Southern California Keck School of Medicine, Los Angeles, CA.
  • Harb J; Moffitt Cancer Center, Tampa, FL.
  • Hutti JE; AbbVie Inc, North Chicago, IL.
  • Holes L; AbbVie Inc, North Chicago, IL.
  • Masud AA; AbbVie Inc, North Chicago, IL.
  • Nuthalapati S; AbbVie Inc, North Chicago, IL.
  • Potluri J; AbbVie Inc, North Chicago, IL.
  • Pemmaraju N; AbbVie Inc, North Chicago, IL.
J Clin Oncol ; 40(15): 1671-1680, 2022 05 20.
Article en En | MEDLINE | ID: mdl-35180010
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Mielofibrosis Primaria Tipo de estudio: Prognostic_studies Límite: Adult / Humans Idioma: En Revista: J Clin Oncol Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Mielofibrosis Primaria Tipo de estudio: Prognostic_studies Límite: Adult / Humans Idioma: En Revista: J Clin Oncol Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Estados Unidos